ITM SE CBO Sebastian Marx
ITM Appoints Dr. Sebastian Marx as Chief Business Officer and Member of Executive Board
22 juil. 2022 05h00 HE | ITM Isotope Technologies Munich SE
Garching / Munich, July 22, 2022 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the appointment of Dr. Sebastian Marx to its Executive Board...
ITM_Logo_Claim_RGB_high-res.png
ITM Signs Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177
21 juil. 2022 05h21 HE | ITM Isotope Technologies Munich SE
ITM to supply its medical radioisotope, no-carrier-added Lutetium-177, for the clinical development of Y-mAbs’ Targeted Radionuclide Therapy candidate GD2-SADA: 177Lu-DOTA Complex for GD2-positive...
AMR Logo.png
Radiotherapy Market Is Expected to Reach $11.9 Billion by 2031, Claims AMR
07 juil. 2022 07h50 HE | Allied Market Research
Portland, OR, July 07, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global radiotherapy market generated $6.5 billion in 2021, and is projected to reach...
Global Radiation Therapy Market
Global Radiation Therapy Market Report 2022: Surging Incidence of Cancer Cases & Rising Healthcare Expenditure to Drive Growth
06 juil. 2022 05h03 HE | Research and Markets
Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has been added to...
ITM_Logo_Claim_RGB_high-res.png
ITM: New Isotope Production System at Bruce Power Successfully Produces First Medical Isotope
21 juin 2022 11h45 HE | ITM Isotope Technologies Munich SE
First-of-a-kind Isotope Production System continues to progress towards commercial, industrial-scale production of medical isotopes for cancer therapeutics ONTARIO, CANADA, and MUNICH, GERMANY – June...
ITM_Logo_Claim_RGB_high-res.png
ITM to Host Symposium on Actinium-225 Targeted Radionuclide Therapy and to Present Phase III COMPOSE Trial Design at the Theranostics World Congress
15 juin 2022 05h00 HE | ITM Isotope Technologies Munich SE
Garching / Munich, June 15, 2022 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host an industry-sponsored lunch symposium on...
22157.jpg
World Radiotherapy Positioning Devices Market - Compound Annual Growth of 8.01% Forecast During 2021-2030
13 mai 2022 04h18 HE | Research and Markets
Dublin, May 13, 2022 (GLOBE NEWSWIRE) -- The "Global Radiotherapy Positioning Devices Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global radiotherapy...
Global Medical Radiation Detection, Monitoring, & Safety Market
Global Medical Radiation Detection, Monitoring & Safety Market Report 2022-2027: Gas-Filled Detectors, Personal Dosimeters, Full-Body Protection, Hospitals Segments Dominate the Market
05 mai 2022 04h33 HE | Research and Markets
Dublin, May 05, 2022 (GLOBE NEWSWIRE) -- The "Global Medical Radiation Detection, Monitoring & Safety Market by Detector (Gas-Filled, Scintillators, Solid-State), Product (Personal Dosimeters,...
Color Logo.png
Global Lung Cancer Therapeutics Market was valued at USD 9.92 billion in 2021 and projected to grow at a CAGR of 10.74% during the forecast period 2022-2028 : Greyviews
13 avr. 2022 04h30 HE | GreyViews
Pune, India, April 13, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
Global Brachytherapy Treatment Planning Systems Market
Global Brachytherapy Treatment Planning Systems Market (2022 to 2030) - Size, Share & Trends Analysis Report
30 mars 2022 06h03 HE | Research and Markets
Dublin, March 30, 2022 (GLOBE NEWSWIRE) -- The "Brachytherapy Treatment Planning Systems Market Size, Share & Trends Analysis Report by Component (PET/CT Deformable, Auto-Contouring...